Abstract
This study investigates the perception of a multinational group of nephrologists on artificial intelligence (AI) application in clinical practice. A validated on-line survey was performed in March 2024, in 4 continents. The results revealed a prevalent familiarity with AI and machine learning (ML) terms, but traditional tools remained favored for clinical decision support. AI's future relevance was acknowledged by more than two thirds of the sample but concerns related to the use of this tool in clinical practice were shared, particularly by nephrologists without any previous contact with AI. This reinforces the need for education in this group of health professionals, to allow full adoption of AI in the management of chronic kidney disease (CKD) in the near future.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
